U.S. markets open in 45 minutes
  • S&P Futures

    3,816.00
    -0.75 (-0.02%)
     
  • Dow Futures

    31,268.00
    +32.00 (+0.10%)
     
  • Nasdaq Futures

    12,684.25
    +2.50 (+0.02%)
     
  • Russell 2000 Futures

    2,204.00
    -1.80 (-0.08%)
     
  • Crude Oil

    61.83
    +0.55 (+0.90%)
     
  • Gold

    1,713.20
    -2.60 (-0.15%)
     
  • Silver

    26.14
    -0.25 (-0.94%)
     
  • EUR/USD

    1.2037
    -0.0031 (-0.25%)
     
  • 10-Yr Bond

    1.4670
    -0.0030 (-0.20%)
     
  • Vix

    26.34
    +2.24 (+9.29%)
     
  • GBP/USD

    1.3962
    +0.0009 (+0.07%)
     
  • USD/JPY

    107.4390
    +0.4370 (+0.41%)
     
  • BTC-USD

    49,464.15
    -2,683.06 (-5.15%)
     
  • CMC Crypto 200

    990.43
    +3.22 (+0.33%)
     
  • FTSE 100

    6,642.82
    -32.65 (-0.49%)
     
  • Nikkei 225

    28,930.11
    -628.99 (-2.13%)
     

INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Cellular Biomedicine Group, Inc. - CBMG

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, Aug. 13, 2020 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Cellular Biomedicine Group, Inc. ("CBMG" or the "Company") (Nasdaq: CBMG) relating to its sale to a consortium that includes members of CBMG management and several entities. Under the terms of the agreement, CBMG shareholders will receive $19.75 in cash for each share of CBMG stock they own.

Monteverde & Associates PC Logo
Monteverde & Associates PC Logo

The investigation focuses on whether Cellular Biomedicine Group, Inc. and its Board of Directors violated securities laws and/or breached their fiduciary duties to the Company by 1) failing to conduct a fair process and 2) whether and by how much this proposed transaction undervalues the Company.

Click here for more information: https://www.monteverdelaw.com/case/cellular-biomedicine-group-inc-0. It is free and there is no cost or obligation to you.

About Monteverde & Associates PC

We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2019 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.

If you own stock in Cellular Biomedicine Group, Inc. and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Cell: (646) 522-4840

Attorney Advertising. (C) 2020 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

Cision
Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/investor-alert-monteverde--associates-pc-announces-an-investigation-of-cellular-biomedicine-group-inc--cbmg-301112091.html

SOURCE Monteverde & Associates PC